Publications by authors named "Amy Simcoe"

Claim this Profile
H
HIV-1 reverse transcriptase plus-strand initiation exhibits preferential sensitivity to non-nucleoside reverse transcriptase inhibitors in vitro.
Jay A Grobler, Geetha Dornadula, Michele R Rice, Amy L Simcoe, Daria J Hazuda

J Biol Chem· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus.
Zhijian Lu, Joann Bohn, Tom Rano, Carrie A Rutkowski, Amy L Simcoe

Bioorg Med Chem Lett· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay.
Steven W Ludmerer, Donald J Graham, Evelyn Boots, Edward M Murray, Amy Simcoe

Antimicrob Agents Chemother· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a key determinant of hepatitis C virus cell culture adaptation in domain II of NS3 helicase.
Jay A Grobler, Eric J Markel, John F Fay, Donald J Graham, Amy L Simcoe

J Biol Chem· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of highly potent HIV protease inhibitors with activity against resistant virus.
Zhijian Lu, Subharekha Raghavan, Joann Bohn, Mark Charest, Mark W Stahlhut, Amy L Simcoe

Bioorg Med Chem Lett· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of hepatitis C virus RNA replication by 2'-modified nucleoside analogs.
Steven S Carroll, Joanne E Tomassini, Michele Bosserman, Krista Getty, Mark W Stahlhut, Amy L Simcoe

J Biol Chem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis